ARVN (Arvinas) FFO


ARVN Arvinas Inc ARVN
70 GF Score
Price $8.00
GF Value $11.82
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Arvinas FFO?

FFO (Funds from operations) only applies to REITs.

ARVN
70GF Score
Arvinas Inc ARVN
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Arvinas (ARVN) Overvalued in 2026?

Based on GuruFocus' analysis, Arvinas stock appears to be undervalued. The current stock price of $8.00 is trading 32.3% below its estimated GF Value™ of $11.82. GuruFocus considers Arvinas to be Possible Value Trap.

Key valuation signals for ARVN:

  • FFO:
  • GF Value™: $11.82 vs. price of $8.00 (32.3% below fair value)
  • GF Score™: 70/100 with 6 warning signs

No single metric tells the full story. See the ARVN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Arvinas Business Description

Address 395 Winchester Avenue, 5 Science Park, New Haven, CT, USA, 06511
Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.
70GF Score

Get the complete analysis for ARVN

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.00
Price
$11.82
GF Value